Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.

Israelow B, Narbus CM, Sourisseau M, Evans MJ.

Hepatology. 2014 Oct;60(4):1170-9. doi: 10.1002/hep.27227. Epub 2014 Aug 21.

2.

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, Narbus CM, Parra Martín A, Evans MJ.

PLoS Pathog. 2013 Mar;9(3):e1003244. doi: 10.1371/journal.ppat.1003244. Epub 2013 Mar 21.

3.

HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.

Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, Zeiner GM, Evans MJ.

J Virol. 2011 Nov;85(22):12087-92. doi: 10.1128/JVI.05843-11. Epub 2011 Sep 14.

4.

Species-specific regions of occludin required by hepatitis C virus for cell entry.

Michta ML, Hopcraft SE, Narbus CM, Kratovac Z, Israelow B, Sourisseau M, Evans MJ.

J Virol. 2010 Nov;84(22):11696-708. doi: 10.1128/JVI.01555-10. Epub 2010 Sep 15.

Supplemental Content

Loading ...
Support Center